Lack of differential pattern in central adiposity and metabolic syndrome in Barrett's esophagus and gastroesophageal reflux disease

Diseases of the Esophagus

Volumn 23, Issue 5, 2010, Pages 386-391

  Healy, L A ^a   Ryan, A M ^a   Pidgeon, G ^a   Ravi, N ^a   Reynolds, J V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Barrett's esophagus; Central obesity; Gastroesophageal reflux disease; Metabolic syndrome; Obesity

Indexed keywords

C REACTIVE PROTEIN; INSULIN; LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; BARRETT ESOPHAGUS; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; LABORATORY TEST; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REGISTER; RISK FACTOR; STATISTICAL SIGNIFICANCE; ABDOMINAL OBESITY; ADENOCARCINOMA; COMPARATIVE STUDY; COMPLICATION; ESOPHAGEAL NEOPLASMS; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; METABOLIC SYNDROME X; METAPLASIA; MIDDLE AGED; OBESITY, ABDOMINAL;

EID: 77954939541     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01052.x     Document Type: Article

References (28)

1. Ryan A M, Rowley S P, Fitzgerald A P, Ravi N, Reynolds J V. Adenocarcinoma of the esophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer 2006, 42:1151-8.
2. Lagergren J, Bergström R, Nyrén O. Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999, 130:883-90.
3. Chow W H, Blot W J, Vaughan T L. Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia. J Natl Cancer Inst 1998, 90:150-5.
4. Vaughan T L, Davis S, Kristal A, Thomas D B. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995, 4:85-92.
5. Brown L M, Swanson C A, Gridley G. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995, 87:104-9.
6. Hampel H, Abraham N S, El-Serag H B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 43:199-211.
7. Pandolfino J E, El-Serag H B, Zhang Q, Shah N, Ghosh S K, Kahrilas P J. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006, 130:639-49.
8. Calle E E, Rodriguez C, Walker-Thurmund K, Thun M J. Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-38.
9. Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-9.
10. Qiao Q, Laatikainen T, Zethelius B. Comparison of definitions of metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohorts. Stroke 2009, 40:337-43.
11. Waterhouse D F, McLaughlin A M, Sheehan F. An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population. Ir J Med Sci 2009, 178:161-6.
12. Ryan A M, Healy L A, Power D G. Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg 2008, 247:909-15.
13. Cook M B, Greenwood D C, Hardie L J, Wild C P, Forman D. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 2008, 103:292-300.
14. Edelstein Z R, Bronner M P, Rosen S N, Vaughan T L. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007, 133:403-11.
15. Corley D A, Kubo A, Levin T R. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007, 133:34-41.
16. Rubenstein J H, Dahlkemper B A, Kao J. A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol 2008, 103:1358-64.
17. Kendall B J, Macdonald G A, Hayward N K. Leptin and the risk of Barrett's esophagus. Gut 2008, 57:488-54.
18. Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-19.
19. Alberti K G, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006, 23:469-80.
20. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (AdultTreatment Panel III). JAMA 2001, 285:2486-97. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
21. El-Serag H B, Kvapil P, Hacken-Bitar J, Kramer J R. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005, 100:2151-6.
22. Gerson L B, Ullah N, Fass R, Green C, Shelter K, Singh G. Does body mass index differ between patients with Barrett's esophagus and patients with chronic gastrooesophageal reflux disease. Aliment Pharmacol Ther 2007, 25:1079-86.
23. Jacobson B C, Chan A T, Giovannucci E L, Fuchs C S. Body mass index and Barrett's oesophagus in women. Gut 2009, 58:1460-6.
24. Sattar N, McConnachie A, Shaper G A. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008, 371:1927-35.
25. Lund Haheim L, Wisloff T F, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006, 164:769-74.
26. Sandhofer A, Iglseder B, Paulweber B, Ebenbichler C F, Patsch J R. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest 2007, 37:109-16.
27. Chung S J, Kim D, Park M J. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case control study of 7078 Koreans undergoing health check-ups. Gut 2008, 57:1360-5.
28. Lee Y C, Yen A M F, Tai J J. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009, 58:174-81.